Nuzenio

Tradingview Beone Medicines

Tradingview Beone Medicines entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 8 latest news signals 1 publisher sources 100/100 entity strength

Latest news

BeOne Medicines Ltd. Stock 12‑Month Price Target Raised to $419.74, Implies 30% Upside - TradingViewTradingView · Wed, 05 Aug 2026 21:20:15 GMTBeOne Medicines: Q2 revenue up 30%, BRUKINSA leads growth, guidance raised, and pipeline advances drive outlook - TradingViewTradingView · Wed, 05 Aug 2026 18:46:59 GMTBeOne Medicines Q2 Earnings Call Highlights - TradingViewTradingView · Wed, 05 Aug 2026 18:04:16 GMTBeone Medicines AG H1 Net Profit Up 627.1% Y/Y - TradingViewTradingView · Wed, 05 Aug 2026 10:29:19 GMTBeOne Medicines: Q2 2026 delivered 30% revenue growth, raised guidance, and advanced key pipeline programs - TradingViewTradingView · Wed, 05 Aug 2026 10:26:33 GMTBeOne Medicines: Q2 2026 revenue up 30% to $1.7B, net income up 151%, driven by strong product sales and margin gains - TradingViewTradingView · Wed, 05 Aug 2026 10:16:09 GMTBeOne Medicines: Q2 2026 revenue up 30% to $1.7B, with raised guidance and strong oncology portfolio growth - TradingViewTradingView · Wed, 05 Aug 2026 10:14:34 GMTBeOne Medicines posts Q2 revenue $1.705B, raises 2026 revenue guidance to $6.6–6.8B - TradingViewTradingView · Wed, 05 Aug 2026 10:13:01 GMT

Timeline

Wed, 05 Aug 2026 21:20:15 GMTBeOne Medicines Ltd. Stock 12‑Month Price Target Raised to $419.74, Implies 30% Upside - TradingView
Wed, 05 Aug 2026 18:46:59 GMTBeOne Medicines: Q2 revenue up 30%, BRUKINSA leads growth, guidance raised, and pipeline advances drive outlook - TradingView
Wed, 05 Aug 2026 18:04:16 GMTBeOne Medicines Q2 Earnings Call Highlights - TradingView
Wed, 05 Aug 2026 10:29:19 GMTBeone Medicines AG H1 Net Profit Up 627.1% Y/Y - TradingView
Wed, 05 Aug 2026 10:26:33 GMTBeOne Medicines: Q2 2026 delivered 30% revenue growth, raised guidance, and advanced key pipeline programs - TradingView
Wed, 05 Aug 2026 10:16:09 GMTBeOne Medicines: Q2 2026 revenue up 30% to $1.7B, net income up 151%, driven by strong product sales and margin gains - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Beone Medicines.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.